Alzchem Group Ag (ALZCF) Q3 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, ladies and gentlemen, and a warm welcome to today's earnings call of the ArtsChem Group AG following the publication of the Q3 figures of 2024. I'm delighted to welcome the CEO Andreas Niedermeyer, CSO Dr. Georg Weichselbaumer, as well as CFO Andreas Loesler. So the gentlemen will speak in a moment and guide us through the presentation and the results. So after the presentation, we will move over to our Q&A session. in which you will be allowed to place your questions directly to the management. So having said this, Mr. Nehemiah, this stage is yours. Yeah, thank you for your warm introduction and good morning together. Thank you for joining us today and welcome to our third quarter call. Actually, as always, we will go through the presentation first and then be available for questions at the end of the presentation. So let's skip the first pages and go directly to the page five, to the highlights. There is a whole range of positive news to report this quarter for sure. So we are able to continue to set ourselves apart from the general downward trend in the chemical industry. So we have developed particularly strongly in the area of specialties. As a result, we were even able to grow revenue in the group as a whole, increased EBITDA by 36% to €76.8 million, and at the same time increased the EBITDA margin to a very respectable 18.5% here. So in terms of the outlook, we assume that although we will achieve sales at the lower end, we will perform in the earnings above €1 million. So 100 million. So we will hear another more detailed financial analysis of the successful figures later from my colleague Andreas Loesler. So this is only a short first summary here. So what I personally was particularly pleased about was the inclusion in the SDACs. In recent yea...